Active Arthritis & Pain Studies

We are constantly seeking participants for a number of studies. Please apply to any studies for which you may qualify, or call us at (417) 883-7889 for more information!

If You Suffer from Arthritis, Clinvest Is Here to Help

Aching fingers, painful knees, and overall joint stiffness can lock up your lifestyle. Join a Clinvest Research study to help advance medical knowledge of an array of arthritic conditions including Rheumatoid Arthritis, Psoriatic Arthritis, Giant Cell Arteritis, and Ankylosing Spondylitis.

Clinvest knows how challenging and frustrating arthritis difficulties can be. We have a strong commitment to further treatment through specialized research studies including: Rheumatoid, Psoriatic, Giant Cell Arteritis, and Ankylosing Spondylitis. We partner with pharmaceutical companies in an effort to discover solutions for such debilitating conditions and look forward to the new horizons in health and well-being.

    Fibromyalgia Research Study

    Teva Fibro 20028

    The purpose of this research study is to assess the effectiveness and safety of an investigational study medication at multiple dosages compared to a placebo in adults with Fibromyalgia. Participation in this study is approximately 21 weeks including up to a 5 week screening period and 16 week double-blind treatment period. There will be approximately 7 visits. The study medication and all study-related procedures are provided to eligible participants at no cost (including basic study-related physical exams, ECG’s and lab tests). If you qualify to participate, reimbursement may be provided for your time.

    Duration: 21 Weeks


    Number: 7 Visits

    Psoriatic Arthritis Research Study

    Sparc Inspire II

    The purpose of this research study is to assess the study medication Tildrakizumab in Anti-TNF naive subjects with active psoriatic arthritis. The study had both a placebo-controlled phase and an open-label period. Completion of the study would involve coming into the office for 19 visits over approximately 64-week period. Your first appointment would last approximately 2-3 hours. If you qualify and choose to volunteer, we would provide the study drug and all study-related procedures at no cost to you (including basic study-related physical exams, bloodwork, ECG’s, XRAYS and urine drug/pregnancy tests).

    Duration: 64 Weeks


    Number: 19 Visits

    Psoriatic Arthritis Research Study

    TILD-19-07 - Sparc Inspire I

    The purpose of this research study is to assess the investigational study drug, tildrakizumab, in subjects with active psoriatic arthritis. This study has both a placebo-controlled phase and an open-label period. Completion of the study would involve coming into the office for a total of 19 visits over approximately 64-week period. You would also be required to have x-rays of your hands and feet 4 times during the study. Your first appointment would last approximately 2-3 hours. If you qualify and choose to volunteer, we would provide investigational study drug and all study-related procedures at no cost to you (including basic study-related physical exams, bloodwork, ECG’s, x-rays and urine drug/pregnancy tests). Compensation will be provided for your time and travel.

    Duration: 64 Weeks


    Number: 19 Visits

    Rheumatoid Arthritis Device Study

    Vorso (RA Protection)

    Dr. True and Clinvest are seeking volunteers in the Springfield area with Rheumatoid Arthritis. The purpose of this research study is to evaluate the safety and efficacy of a device (the Vorso PROTECT System) for the treatment of subjects with active rheumatoid arthritis. Qualified volunteers will be asked to attend up to 5 visits over 12 weeks. All participants will be asked to use the Vorso System once a day for 15 minutes. If you qualify and choose to volunteer, we would provide the study device, as well as all study-related procedures at no cost to you (including basic study-related physical exams, bloodwork, ECG’s, and urine drug/pregnancy tests). You would be asked to fill out more detailed questionnaires during the appointments. Participants will be compensated up to $400 for their time attending office visits.

    Duration: 12 Weeks


    Number: 5 Visits

    Giant Cell Arteritis Study

    Abbvie M16-852

    Eligible subjects over 50 years in age who have been newly diagnosed or have relapsing Giant Cell Arteritis. Participants will be randomized to receive either standard of care or investigational product in addition to standard of care for up to two years over 21 visits. Your first appointment would last approximately 2 hours. If you qualify and choose to volunteer, we would provide investigational study pills, or standard of care pills and all study-related procedures at no cost to you (including basic study-related physical exams, bloodwork, ECG’s, and urine drug/pregnancy tests). Compensation may be provided for your time and travel.

    Duration: Up to 2 Years


    Number: 21

Want to find out when new studies are available?

Fill out the form!